Market Research Logo

Global Markets for Animal Therapeutics and Diagnostics

Global Markets for Animal Therapeutics and Diagnostics

The global market for animal therapeutics and diagnostics totaled nearly $40.1 billion in 2016 and should total $47.9 billion in 2021, registering a compound annual growth rate (CAGR) of 3.6% for the period 2016-2021.

Report Includes
An overview of the global markets for animal therapeutics and diagnostics
Analyses of global market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021
Details about products currently in the market
Analysis of the competitive environment
A look at keys to market success including identifying the next growth segment, developing the right product candidates, and being the first to market
Analysis of the market's dynamics, specifically growth drivers, inhibitors, and opportunities
Profiles of major players in the industry

Report Scope
This BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the animal therapeutics and diagnostics market. The geographical scope of this study is worldwide, with special interest for markets, trends and statistics by key geographical regions such as the United States, European countries and Brazil, Japan and Australia. The report identifies markets in four segments: vaccines, pharmaceuticals, feed additives and diagnostics. For the purpose of this study, diagnostics include products that are used at the point of care and are considered rapid tests or kits, in-clinic analyzers and imaging equipment. Each market segment provides detailed information based on product categories, use of products, forecasts and competitive analyses.


Report Scope
This BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the animal therapeutics and diagnostics market. The geographical scope of this study is worldwide, with special interest for markets, trends and statistics by key geographical regions such as the United States, European countries and Brazil, Japan and Australia. The report identifies markets in four segments: vaccines, pharmaceuticals, feed additives and diagnostics. For the purpose of this study, diagnostics include products that are used at the point of care and are considered rapid tests or kits, in-clinic analyzers and imaging equipment. Each market segment provides detailed information based on product categories, use of products, forecasts and competitive analyses.

CHAPTER 1 INTRODUCTION
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
INTENDED AUDIENCE
SCOPE OF REPORT
INFORMATION SOURCES
RELATED BCC RESEARCH REPORTS
ANALYST'S CREDENTIALS
BCC RESEARCH WEBSITE
DISCLAIMER
CHAPTER 2 SUMMARY
MARKET OVERVIEW
SUMMARY TABLE GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS, BY PRODUCT SEGMENT, THROUGH 2021 ($ MILLIONS)
SUMMARY FIGURE GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS, BY PRODUCT SEGMENT, 2014-2021 ($ MILLIONS)
LEADING MANUFACTURERS AND SUPPLIERS
CHAPTER 3 INDUSTRY OVERVIEW
ANIMAL ANATOMY AND PHYSIOLOGY
REPRODUCTIVE SYSTEM
TABLE 1 GESTATION PERIODS OF SELECT COMMON SPECIES
AVIAN ANATOMY
TABLE 2 LIFESPAN OF COMMON AVIAN SPECIES OF PETS
ANIMAL POPULATIONS IN THE UNITED STATES
COMPANION ANIMALS
TABLE 3 STATISTICS FOR COMPANION ANIMALS FOUND IN U.S. HOUSEHOLDS, 2011, 2014 AND 2016 (THOUSANDS/%)
TABLE 4 ESTIMATED POPULATIONS OF COMPANION ANIMALS FOUND IN U.S. HOUSEHOLDS, 2014 AND 2016 (THOUSANDS)
FOOD PRODUCTION ANIMALS
TABLE 5 REPORTED POPULATION OF FOOD PRODUCTION ANIMALS IN THE UNITED STATES, 2005, 2010, 2014, 2016 AND PROJECTED 2017 (THOUSANDS)
Livestock Production - Top States
TABLE 6 TOP BROILER PRODUCING STATES, 2015 (THOUSANDS)
TABLE 7 TOP RED MEAT PRODUCING STATES, 1990 AND 2015 (%)
ANIMAL POPULATIONS BY COUNTRY
DOGS
TABLE 8 DOG (CANINE) POPULATION BY SELECT COUNTRY, 2015 (THOUSANDS)
CATS
TABLE 9 CAT (FELINE) POPULATION BY SELECT COUNTRY, 2015 (THOUSANDS)
HORSES
TABLE 10 HORSE (EQUINE) POPULATION BY COUNTRY, 2016 (THOUSANDS)
CATTLE
TABLE 11 CATTLE (BOVINE) POPULATION BY COUNTRY, 2016 (THOUSANDS)
SWINE
TABLE 12 PIG/HOG (SWINE) POPULATION BY COUNTRY, 2016 (THOUSANDS)
SHEEP
GOATS
ZOONOTIC DISEASES
TABLE 13 COMMON EXAMPLES OF ZOONOTIC DISEASES
CHAPTER 4 ISSUES AFFECTING THE MARKET
OVERVIEW
LEGAL AND REGULATORY ISSUES
REGULATORY AGENCIES INVOLVED IN ANIMAL HEALTH AND WELFARE
Food and Drug Administration (FDA)
FDA's Center for Veterinary Medicine (CVM)
U.S. Department of Agriculture (USDA)
European Medicines Agency (EMA) and Committee for Medicinal Products
for Veterinary Use (CVMP)
Australian Pesticides and Veterinary Medicines Authority (APVMA)
The Ministry of Agriculture, Livestock and Supply (MAPA) of Brazil
ANTIBIOTIC USE AND RESISTANCE IN PRODUCTION ANIMALS
FDA's Antimicrobial Restrictions
TABLE 14 AFFECTED PIONEER ANTIMICROBIALS USED IN
FOOD-PRODUCING ANIMALS IN THE UNITED STATES
Losing Livestock
Corporate Response Concerning Responsible Use
Therapeutic Use
Resistance
TABLE 15 ANTIMICROBIAL DRUG USE AND SALES IN
FOOD-PRODUCING ANIMALS, 2010, 2011 AND 2014
(KG*)
Human Side Effects
Microbial Ecology
Agriculture and Food Research Initiative
Levels of Contaminated Meats in the U.S.
Movement for Lower Amounts of Antibiotics in Livestock Production
MINIMALLY AND HIGHLY REGULATED PRODUCTS
ANIMAL DRUG USER FEE ACT OF 2003
ANIMAL DRUG USER FEE AMENDMENTS OF 2008 (ADUFA II)
ANIMAL DRUG USER FEE AMENDMENTS OF 2013 (ADUFA III)
BIOTECHNOLOGY IN ANIMAL HEALTH
ANIMAL CLONING
PROBIOTICS
ANIMAL OBESITY
CAUSES
WEIGHT REDUCTION
TRENDS IN COMPANION PET OWNERSHIP
ANIMAL HEALTH INSURANCE
TABLE 16 APPA NATIONAL PET OWNERS SURVEY, 2013 AND 2014 BASIC ANNUAL EXPENSES FOR DOGS AND CATS (U.S. SPENDING, $)
TABLE 17 PET INSURANCE PLAN COMPARISONS, UNITED STATES
ADVANCED MEDICAL PROCEDURES
LIFE CYCLE APPROACH
DEMAND IN THE VETERINARY SERVICE INDUSTRY
TABLE 18 NUMBER OF VETERINARIANS AND PARAVETERINARIAN ASSISTANTS, TOP 10 COUNTRIES, 2012 VS. 2015
FIGURE 1 NUMBER OF VETERINARIANS AND PARAVETERINARIAN ASSISTANTS, TOP 10 COUNTRIES, 2012 VS 2015
TABLE 19 ESTIMATED NUMBER OF U.S. PRIVATE VETERINARIAN PRACTICES, BY TYPE OF PRACTICE, 2013 AND 2015
TABLE 20 GLOBAL MARKET FOR ANIMAL VACCINES BY ANIMAL GROUP, THROUGH 2021 ($ MILLIONS)
FIGURE 2 ESTIMATED NUMBER OF VETERINARIANS IN THE UNITED STATES BY GENDER* AND YEAR, 2009-2015
CHAPTER 5 ANIMAL VACCINES
OVERVIEW
GLOBAL MARKET ANALYSIS AND CONSIDERATIONS
TABLE 21 GLOBAL MARKET FOR ANIMAL VACCINES BY ANIMAL GROUP, THROUGH 2021 ($ MILLIONS)
FIGURE 3 GLOBAL MARKET SHARES OF ANIMAL VACCINES BY ANIMAL GROUP, 2016 (%)
GLOBAL MARKET BY GEOGRAPHICAL REGION
TABLE 22 GLOBAL MARKET FOR ANIMAL VACCINES BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 4 GLOBAL MARKET SHARES OF ANIMAL VACCINES BY REGION, 2016 (%)
COMPETITIVE SUMMARY
TABLE 23 GLOBAL MARKET SHARES OF ANIMAL VACCINE SUPPLIERS BASED ON COMPETITOR REVENUES, 2016 ($ MILLIONS/%)
FIGURE 5 GLOBAL MARKET SHARES OF ANIMAL VACCINE SUPPLIERS BASED ON COMPETITOR REVENUES, 2016 (%)
PRODUCT INTRODUCTION
ACTIVE IMMUNITY
PASSIVE IMMUNITY
OTHER TYPES
COMPANION ANIMALS
VIRUSES
Adenovirus
Avian Influenza
Coronavirus
Distemper
Eastern Equine Encephalitis
Equine Viral Arteritis
Feline Calicivirus and Feline Herpes Virus
Feline Immunosuppressive Virus
Feline Infectious Peritonitis Virus
Feline Leukemia Virus
Hendra Virus
TABLE 24 HENDRA VIRUS EQUINE INCIDENTS (NUMBER OF REPORTED CASES)
Infectious Hepatitis
Internal Papillomatosis of Parrots
Newcastle Disease
Pacheco's Disease
Parainfluenza Virus
Paramyxoviruses
Parvovirus
Polyomavirus
Poxviruses
Psittacine Beak and Feather Disease
Rabies
Reovirus
West Nile Virus
VACCINE PROVIDERS
Boehringer Ingelheim/Vetmedica
TABLE 25 BOEHRINGER INGELHEIM'S COMPANION ANIMAL VACCINES BY TARGET SPECIES
FIGURE 6 BOEHRINGER INGELHEIM'S COMPANION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
Elanco
TABLE 26 ELANCO'S COMPANION ANIMAL VACCINES BY TARGET SPECIES
Merck Animal Health
TABLE 27 MERCK'S COMPANION ANIMAL VACCINES BY TARGET SPECIES
FIGURE 7 MERCK'S COMPANION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
Merial
TABLE 28 MERIAL'S COMPANION ANIMAL VACCINES BY TARGET SPECIES
FIGURE 8 MERIAL'S COMPANION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
Zoetis
TABLE 29 ZOETIS' COMPANION ANIMAL VACCINES BY TARGET SPECIES
FIGURE 9 ZOETIS' COMPANION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
COMPANION ANIMAL VACCINES MARKET ANALYSIS
FIGURE 10 GLOBAL MARKET FOR COMPANION ANIMAL VACCINES BY ANIMAL SPECIES, 2014-2021 ($ MILLIONS)
FIGURE 11 GLOBAL REVENUES FOR COMPANION ANIMAL VACCINES BY TYPE, 2014-2021 ($ MILLIONS)
PRODUCTION ANIMALS
VIRUSES AND PRIONS
Avian Pneumovirus
Bovine Spongiform Encephalopathy
Bovine Viral Diarrhea
Classical Swine Fever
Foot and Mouth Disease
Furunculosis
Infectious Pancreatic Necrosis
Marek's Disease
Pathogenic Avian Influenza
Q Fever
Vesicular Stomatitis
VACCINE PROVIDERS
Bayer
TABLE 30 BAYER'S PRODUCTION ANIMAL VACCINES BY TARGET SPECIES
Boehringer Ingelheim
TABLE 31 BOEHRINGER INGELHEIM'S PRODUCTION ANIMAL VACCINES BY TARGET SPECIES
FIGURE 12 BOEHRINGER INGELHEIM'S PRODUCTION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016
Elanco
TABLE 32 ELANCO'S PRODUCTION ANIMAL VACCINES BY TARGET SPECIES
FIGURE 13 ELANCO'S PRODUCTION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
Merck & Co.
TABLE 33 MERCK & CO'S PRODUCTION ANIMAL VACCINES BY TARGET SPECIES
FIGURE 14 MERCK'S PRODUCTION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
Merial
TABLE 34 MERIAL'S PRODUCTION ANIMAL VACCINES BY TARGET SPECIES
FIGURE 15 MERIAL'S PRODUCTION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
Zoetis
TABLE 35 ZOETIS' PRODUCTION ANIMAL VACCINES BY TARGET SPECIES
FIGURE 16 ZOETIS' PRODUCTION ANIMAL VACCINES, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
PRODUCTION ANIMAL VACCINE MARKET ANALYSIS
FIGURE 17 GLOBAL MARKET FOR PRODUCTION ANIMAL VACCINES BY ANIMAL SPECIES, 2014-2021
FIGURE 18 GLOBAL MARKET FOR PRODUCTION ANIMAL VACCINES BY TYPE, 2014-2021 ($ MILLIONS)
CHAPTER 6 ANIMAL PHARMACEUTICAL PRODUCTS
OVERVIEW
GLOBAL MARKET ANALYSIS AND CONSIDERATIONS
TABLE 36 GLOBAL MARKET FOR ANIMAL PHARMACEUTICAL PRODUCTS BY TYPE, THROUGH 2021 ($ MILLIONS)
FIGURE 19 GLOBAL MARKET FOR ANIMAL PHARMACEUTICAL PRODUCTS BY TYPE, 2016-2021 ($ MILLIONS)
COMPANION ANIMAL VS. PRODUCTION ANIMAL MARKETS
TABLE 37 GLOBAL MARKET FOR ANIMAL PHARMACEUTICAL PRODUCTS BY ANIMAL GROUP, THROUGH 2021 ($ MILLIONS)
FIGURE 20 GLOBAL MARKET SHARES OF ANIMAL PHARMACEUTICAL PRODUCTS BY ANIMAL GROUP, 2016 (%)
MARKETS BY GEOGRAPHICAL REGION
TABLE 38 GLOBAL MARKET FOR ANIMAL PHARMACEUTICALS BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 21 GLOBAL MARKET SHARES OF ANIMAL PHARMACEUTICALS BY REGION, 2016 (%)
COMPETITIVE SUMMARY
TABLE 39 GLOBAL MARKET SHARES OF ANIMAL PHARMACEUTICAL PRODUCT SUPPLIERS, 2016 ($ MILLIONS)
FIGURE 22 GLOBAL MARKET SHARES OF ANIMAL PHARMACEUTICAL PRODUCT SUPPLIERS BASED ON COMPETITOR REVENUES, 2016 (%)
PRODUCT INTRODUCTIONS
ALLERGY AND RESPIRATORY DRUGS
Companion Animals: Allergy and Inflammatory Diseases
Allergies
Arthritis
Asthma
Dermatitis
Eosinophilic Granuloma Complex
Gout
Target Species and Providers
Boehringer Ingelheim
TABLE 40 BOEHRINGER INGELHEIM'S ALLERGY AND RESPIRATORY
DRUGS BY TARGET SPECIES
Elanco
TABLE 41 ELANCO'S ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES
Heska
TABLE 42 HESKA'S ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES
Huvepharma
TABLE 43 HUVEPHARMA'S ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES
Virbac
TABLE 44 VIRBAC'S ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES
Zoetis
TABLE 45 ZOETIS' ALLERGY AND RESPIRATORY DRUGS BY TARGET SPECIES
FIGURE 23 ZOETIS' ALLERGY AND RESPIRATORY DRUGS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
Allergy and Respiratory Market Analysis
FIGURE 24 GLOBAL MARKET FOR ALLERGY AND RESPIRATORY PRODUCTS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
ANTI-INFECTIVES AND ANTIFUNGALS
Companion Animals - Bacterial Infections
Black Tongue
Bordetella
Brucellosis
Campylobacteriosis
Chlamydia
Leptospirosis
Lyme Disease
Q Fever
Respiratory Mycoplasmosis
Spirochaetaceae
Tetanus
Production Animals - Bacterial Infections
Anthrax
Blackleg
Conjunctivitis
Tetanus
Ehrlichia Ruminantium (previously known as Heartwater)
Pneumonia
Providers
Bayer
TABLE 46 BAYER'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES
FIGURE 25 BAYER'S ANTI-INFECTIVE DRUGS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
Boehringer Ingelheim
TABLE 47 BOEHRINGER INGELHEIM'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES
ECO
TABLE 48 ECO ANIMAL HEALTH'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES
Elanco
TABLE 49 ELANCO'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES
FIGURE 26 ELANCO'S ANTI-INFECTIVE DRUGS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
Esteve
TABLE 50 ESTEVE'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES
Merck Animal Health
TABLE 51 MERCK'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES
FIGURE 27 MERCK'S ANTI-INFECTIVE DRUGS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
Merial - Sanofi
TABLE 52 MERIAL'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES
Virbac
TABLE 53 VIRBAC'S ANTI-INFECTIVE DRUGS BY TARGET SPECIES
Zoetis
TABLE 54 ZOETIS' ANTI-INFECTIVE DRUGS BY TARGET SPECIES
FIGURE 28 ZOETIS' ANTI-INFECTIVE DRUGS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
Anti-Infectives Market Analysis
FIGURE 29 GLOBAL MARKET FOR ANTI-INFECTIVES BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
ANTI-INFLAMMATORIES AND ANALGESICS
Providers
Aratana Therapeutics
TABLE 55 ARATANA THERAPEUTICS' ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES
Bayer
TABLE 56 BAYER ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES
Boehringer Ingelheim
TABLE 57 BOEHRINGER INGELHEIM'S ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES
Elanco
TABLE 58 ELANCO'S ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES
FIGURE 30 ELANCO'S ANTI-INFLAMMATORIES AND ANALGESICS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
Esteve
TABLE 59 ESTEVE'S ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES
Merck Animal Health
TABLE 60 MERCK'S ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES
Merial
TABLE 61 MERIAL'S ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES
Zoetis
TABLE 62 ZOETIS' ANTI-INFLAMMATORIES AND ANALGESICS BY TARGET SPECIES
FIGURE 31 ZOETIS' ANTI-INFLAMMATORIES AND ANALGESICS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
Anti-Inflammatory Market Analysis
FIGURE 32 GLOBAL MARKET FOR ANTI-INFLAMMATORIES AND ANALGESICS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
METABOLIC AND ENDOCRINE DISORDER DRUGS
Metabolic Diseases and Endocrine Disorders
Cushing's Syndrome
Diabetes Mellitus
Thyroid Disease
Pancreatitis
Metabolic Bone Disease in Birds
Providers
Aratana Therapeutics
TABLE 63 ARATANA THERAPEUTICS' METABOLIC AND ENDOCRINE
DRUGS BY TARGET SPECIES
Bayer
TABLE 64 BAYER'S METABOLIC AND ENDOCRINE DRUGS BY TARGET SPECIES
Boehringer Ingelheim
TABLE 65 BOEHRINGER INGELHEIM'S METABOLIC AND ENDOCRINE DRUGS BY TARGET SPECIES
Merck
TABLE 66 MERCK'S METABOLIC AND ENDOCRINE DRUGS BY TARGET SPECIES
FIGURE 33 MERCK'S METABOLIC AND ENDOCRINE DRUGS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES (%)
Merial
TABLE 67 MERIAL'S METABOLIC AND ENDOCRINE DRUGS BY TARGET SPECIES
Virbac
TABLE 68 VIRBAC'S METABOLIC AND ENDOCRINE DRUGS BY TARGET SPECIES
Zoetis
TABLE 69 ZOETIS' METABOLIC AND ENDOCRINE DRUGS BY TARGET SPECIES
FIGURE 34 ZOETIS' METABOLIC AND ENDOCRINE DRUGS, PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
Metabolic Drug Market Analysis
FIGURE 35 GLOBAL MARKET FOR METABOLIC DRUGS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
PARASITICIDES
Companion Animals - Parasitic Diseases
Ear Mites
Fleas
Heartworm
Hemotropic Mycoplasmas (formerly Hemobartonellosis)
Feline Scabies
Lice
Sarcoptic Mange
Worms
Production Animals - Parasitic Disease Example
Texas Cattle Fever
Providers
Bayer
TABLE 70 BAYER'S PARASITICIDES BY TARGET SPECIES
FIGURE 36 BAYER'S PARASITICIDES: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
Beaphar
TABLE 71 BEAPHAR'S PARASITICIDES BY TARGET SPECIES
Boehringer Ingelheim
TABLE 72 BOEHRINGER INGELHEIM'S PARASITICIDES BY TARGET SPECIES
ECO
TABLE 73 ECO ANIMAL HEALTH'S PARASITICIDES BY TARGET SPECIES
Elanco
TABLE 74 ELANCO'S PARASITICIDES BY TARGET SPECIES
FIGURE 37 ELANCO'S PARASITICIDES: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
Huvepharma
TABLE 75 PARASITICIDES BY TARGET SPECIES
Merck Animal Health
TABLE 76 MERCK'S PARASITICIDES BY TARGET SPECIES
FIGURE 38 MERCK'S PARASITICIDES: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
Merial
TABLE 77 MERIAL'S PARASITICIDES BY TARGET SPECIES
FIGURE 39 MERIAL'S PARASITICIDES: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
Virbac
TABLE 78 VIRBAC'S PARASITICIDES BY TARGET SPECIES
Zoetis
TABLE 79 ZOETIS' PARASITICIDES BY TARGET SPECIES
FIGURE 40 ZOETIS' PARASITICIDES: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
Parasiticide Market Analysis
FIGURE 41 GLOBAL MARKET FOR PARASITICIDES BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
PSYCHOTROPIC MEDICATIONS
Providers
Elanco
TABLE 80 ELANCO'S PSYCHOTROPIC MEDICATIONS BY TARGET SPECIES
Vetoquinol
TABLE 81 VETOQUINOL'S PSYCHOTROPIC MEDICATIONS BY TARGET SPECIES
Zoetis
TABLE 82 ZOETIS' PSYCHOTROPIC MEDICATIONS BY TARGET SPECIES
Natural Remedies
Psychotropic Market Analysis
FIGURE 42 GLOBAL MARKET FOR PSYCHOTROPICS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
OTHER PHARMACEUTICALS
Companion Animals - Other Diseases
Equine Protozoal Myelitis
Leptospirosis and Equine Recurrent Uveitis
Urinary Diseases
Glomerulonephritis
Feline Lower Urinary Tract Disease
Neoplastic Disease
Heart Disease
Inflammatory Bowel Disease
Providers
Bayer
TABLE 83 BAYER'S OTHER PHARMACEUTICALS BY TARGET SPECIES
Boehringer Ingelheim
TABLE 84 BOEHRINGER INGELHEIM'S OTHER PHARMACEUTICALS BY TARGET SPECIES
Elanco
TABLE 85 ELANCO'S OTHER PHARMACEUTICALS BY TARGET SPECIES
Esteve
TABLE 86 ESTEVE'S OTHER PHARMACEUTICALS BY TARGET SPECIES
HbO2 Therapeutics LLC
TABLE 87 HBO2 THERAPEUTICS' OTHER PHARMACEUTICALS BY TARGET SPECIES
Merck Animal Health
TABLE 88 MERCK'S OTHER PHARMACEUTICALS BY TARGET SPECIES
Merial
TABLE 89 MERIAL'S OTHER PHARMACEUTICALS BY TARGET SPECIES
Virbac
TABLE 90 VIRBAC'S OTHER PHARMACEUTICALS BY TARGET SPECIES
Zoetis
TABLE 91 ZOETIS' OTHER PHARMACEUTICALS BY TARGET SPECIES
FIGURE 43 ZOETIS' OTHER PHARMACEUTICALS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
Dental
TABLE 92 DENTAL PHARMACEUTICALS BY TARGET SPECIES AND PROVIDER
Other Pharmaceuticals Market Analysis
FIGURE 44 GLOBAL MARKET FOR OTHER PHARMACEUTICALS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
CHAPTER 7 ANIMAL FEED ADDITIVES
OVERVIEW
GLOBAL MARKET ANALYSIS AND CONSIDERATIONS
TABLE 93 GLOBAL MARKET FOR ANIMAL FEED ADDITIVE PRODUCTS BY TYPE, THROUGH 2021 ($ MILLIONS)
FIGURE 45 GLOBAL MARKET FOR ANIMAL FEED ADDITIVE PRODUCTS BY TYPE, 2014-2021 ($ MILLIONS)
COMPANION ANIMAL VS. PRODUCTION ANIMAL MARKETS
TABLE 94 GLOBAL MARKET FOR FEED ADDITIVES BY ANIMAL GROUP, THROUGH 2021
FIGURE 46 GLOBAL MARKET SHARES OF FEED ADDITIVES BY ANIMAL GROUP, 2016 (%)
MARKETS BY GEOGRAPHICAL REGION
TABLE 95 GLOBAL MARKET FOR ANIMAL FEED ADDITIVES BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 47 GLOBAL MARKET SHARES OF ANIMAL FEED ADDITIVES BY REGION, 2016 (%)
COMPETITIVE SUMMARY
TABLE 96 GLOBAL MARKET SHARES OF SUPPLIERS OF ANIMAL FEED ADDITIVES, 2016 ($ MILLIONS/%)
FIGURE 48 GLOBAL MARKET SHARES OF SUPPLIERS OF ANIMAL FEED ADDITIVES, 2016 (%)
PRODUCT INTRODUCTIONS
AMINO ACIDS
Providers
Adisseo - Bluestar
TABLE 97 ADISSEO'S AMINO ACIDS BY TARGET SPECIES
Ajinomoto
TABLE 98 AJINOMOTO'S AMINO ACIDS BY TARGET SPECIES
Boehringer Ingelheim
TABLE 99 BOEHRINGER INGELHEIM'S AMINO ACIDS BY TARGET SPECIES
Evonik
TABLE 100 EVONIK'S AMINO ACIDS BY TARGET SPECIES
Novus International
TABLE 101 NOVUS INTERNATIONAL'S AMINO ACIDS BY TARGET SPECIES
Amino Acid Market Analysis
FIGURE 49 GLOBAL MARKET FOR AMINO ACIDS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
MEDICINAL ADDITIVES
Providers
ECO
TABLE 102 MEDICINAL ADDITIVES BY TARGET SPECIES
Elanco
TABLE 103 ELANCO'S MEDICINAL ADDITIVES BY TARGET SPECIES
FIGURE 50 ELANCO'S MEDICINAL ADDITIVES: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
Huvepharma
Merck
TABLE 104 MERCK'S MEDICINAL ADDITIVES BY TARGET SPECIES
Merial
TABLE 105 MERIAL'S MEDICINAL ADDITIVES BY TARGET SPECIES
Phibro Animal Health
TABLE 106 PHIBRO'S MEDICINAL ADDITIVES BY TARGET SPECIES
Zoetis
TABLE 107 ZOETIS' MEDICINAL ADDITIVES BY TARGET SPECIES
FIGURE 51 ZOETIS' MEDICINAL ADDITIVES: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
Medicinal Feed Additive Market Analysis
FIGURE 52 GLOBAL MARKET FOR MEDICINAL FEED ADDITIVES BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
NUTRITIONAL SUPPLEMENTS
Providers
Adisseo - Bluestar
TABLE 108 ADISSEO (BLUESTAR) NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES
Bayer
TABLE 109 BAYER'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES
BASF
TABLE 110 BASF'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES
Beaphar
TABLE 111 BEAPHAR'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES
Boehringer Ingelheim
TABLE 112 BOEHRINGER INGELHEIM'S NUTRITIONAL
SUPPLEMENTS BY TARGET SPECIES
FIGURE 53 BOEHRINGER INGELHEIM'S NUTRITIONAL SUPPLEMENTS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES (%)
DSM Nutritional Products
TABLE 113 DSM'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES
Elanco
TABLE 114 ELANCO'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES
FIGURE 54 ELANCO'S NUTRITIONAL SUPPLEMENTS: PRODUCT PORTFOLIO ISTRIBUTION BY TARGET SPECIES, 2016 (%)
Esteve
TABLE 115 ESTEVE'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES
Heska
TABLE 116 HESKA'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES
Mosaic
TABLE 117 MOSAIC'S NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES
Virbac
TABLE 118 NUTRITIONAL SUPPLEMENTS BY TARGET SPECIES
Nutritional Supplement Market Analysis
FIGURE 55 GLOBAL MARKET FOR NUTRITIONAL SUPPLEMENTS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
VITAMINS AND MINERALS
Providers
Adisseo - Bluestar
TABLE 119 ADISSEO'S VITAMINS AND MINERALS BY TARGET SPECIES
BASF
TABLE 120 BASF'S VITAMINS AND MINERALS BY TARGET SPECIES
Beaphar
TABLE 121 BEAPHAR'S VITAMINS AND MINERALS BY TARGET SPECIES
DSM Nutritional Products
TABLE 122 DSM'S VITAMINS AND MINERALS BY TARGET SPECIES
Merck Animal Health
TABLE 123 MERCK'S VITAMINS AND MINERALS BY TARGET SPECIES
Zoetis
TABLE 124 ZOETIS' VITAMINS AND MINERALS BY TARGET SPECIES
FIGURE 56 ZOETIS' VITAMINS AND MINERALS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
Vitamin and Mineral Market Analysis
FIGURE 57 GLOBAL MARKET FOR VITAMINS AND MINERALS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
CHAPTER 8 ANIMAL DIAGNOSTICS
OVERVIEW
GLOBAL MARKET ANALYSIS AND CONCLUSION
TABLE 125 GLOBAL MARKET FOR ANIMAL DIAGNOSTICS BY TYPE, THROUGH 2021 ($ MILLIONS)
FIGURE 58 GLOBAL MARKET FOR ANIMAL DIAGNOSTICS BY TYPE, 2014-2021 ($ MILLIONS)
COMPANION ANIMAL VS. PRODUCTION ANIMAL MARKETS
TABLE 126 GLOBAL MARKET FOR ANIMAL DIAGNOSTIC PRODUCTS BY ANIMAL GROUP, THROUGH 2021 ($ MILLIONS)
FIGURE 59 GLOBAL MARKET SHARES OF ANIMAL DIAGNOSTICS BY ANIMAL GROUP, 2016 (%)
MARKETS BY GEOGRAPHICAL REGION
TABLE 127 GLOBAL MARKET FOR ANIMAL DIAGNOSTICS BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 60 GLOBAL MARKET SHARES OF ANIMAL DIAGNOSTICS BY REGION, 2016 (%)
FIGURE 61 GLOBAL MARKET SHARE OF ANIMAL DIAGNOSTICS BY COUNTRY, 2016 (%)
COMPETITIVE SUMMARY
TABLE 128 GLOBAL MARKET SHARES OF ANIMAL DIAGNOSTICS SUPPLIERS BASED ON COMPETITOR REVENUES, 2016 ($ MILLIONS/%)
FIGURE 62 GLOBAL MARKET SHARES OF ANIMAL DIAGNOSTIC SUPPLIERS BASED ON COMPETITOR REVENUES, 2016 (%)
PRODUCT PROVIDERS AND DESCRIPTIONS
ABAXIS
TABLE 129 ABAXIS' DIAGNOSTICS BY TARGET SPECIES
BEAPHAR
TABLE 130 BEAPHAR'S DIAGNOSTICS BY TARGET SPECIES
HESKA
TABLE 131 HESKA'S DIAGNOSTICS BY TARGET SPECIES
FIGURE 63 HESKA'S DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES (%)
IDEXX
TABLE 132 IDEXX'S DIAGNOSTICS BY TARGET SPECIES
FIGURE 64 IDEXX'S DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES (%)
MERCK ANIMAL HEALTH
TABLE 133 MERCK'S DIAGNOSTICS BY TARGET SPECIES
VIRBAC
TABLE 134 VIRBAC'S DIAGNOSTICS BY TARGET SPECIES
FIGURE 65 VIRBAC'S DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
ZOETIS
TABLE 135 ZOETIS' DIAGNOSTICS BY TARGET SPECIES
FIGURE 66 ZOETIS' DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY TARGET SPECIES, 2016 (%)
FIGURE 67 ZOETIS' FELINE DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY DISEASE TARGET, 2016 (%)
FIGURE 68 ZOETIS' CANINE DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY DISEASE TARGET, 2016 (%)
FIGURE 69 ZOETIS' EQUINE DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY DISEASE TARGET, 2016 (%)
FIGURE 70 ZOETIS' RUMINANT DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY DISEASE TARGET, 2016 (%)
FIGURE 71 ZOETIS' SWINE DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY DISEASE TARGET, 2016 (%)
FIGURE 72 ZOETIS' AVIAN DIAGNOSTICS: PRODUCT PORTFOLIO DISTRIBUTION BY DISEASE TARGET, 2016 (%)
PRODUCT SEGMENTS
DIAGNOSTIC RAPID TESTING MARKET ANALYSIS
FIGURE 73 GLOBAL MARKET FOR RAPID DIAGNOSTIC TESTS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
FIGURE 74 GLOBAL MARKET FOR RAPID DIAGNOSTICS BY TEST TYPE (VETERINARY APPLICATIONS), 2014-2021 ($ MILLIONS)
MARKET ANALYSIS OF DIAGNOSTIC ANALYZERS AND CONSUMABLES
FIGURE 75 GLOBAL MARKET FOR DIAGNOSTIC ANALYZERS AND CONSUMABLES BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
FIGURE 76 GLOBAL MARKET FOR DIAGNOSTIC ANALYZERS AND CONSUMABLES BY TEST TYPE (VETERINARY APPLICATIONS), 2014-2021 ($ MILLIONS)
MARKET ANALYSIS OF DIAGNOSTIC IMAGING EQUIPMENT
FIGURE 77 GLOBAL MARKET FOR DIAGNOSTIC IMAGING EQUIPMENT AND RELATED MATERIALS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
CHAPTER 9 MARKET SUMMARY
GLOBAL ANIMAL THERAPEUTICS AND DIAGNOSTICS MARKET ANALYSIS
TABLE 136 GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY PRODUCT SEGMENT, THROUGH 2021 ($ MILLIONS)
FIGURE 78 GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY PRODUCT SEGMENT, 2014-2021 ($ MILLIONS)
MARKETS BY USE OR ANIMAL GROUP
TABLE 137 GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY ANIMAL GROUP THROUGH 2021 ($ MILLIONS)
FIGURE 79 GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY ANIMAL GROUP, 2014-2021 ($ MILLIONS)
FIGURE 80 GLOBAL MARKET SHARES OF ANIMAL THERAPEUTICS AND DIAGNOSTICS BY ANIMAL GROUP, 2016 (%)
MARKETS BY WORLD REGION
TABLE 138 GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY REGION, THROUGH 2021 ($ MILLIONS)
FIGURE 81 GLOBAL MARKET FOR ANIMAL THERAPEUTICS AND DIAGNOSTICS BY REGION, 2014-2021 ($ MILLIONS)
FIGURE 82 GLOBAL MARKET SHARES OF ANIMAL THERAPEUTICS AND DIAGNOSTICS BY REGION, 2016 (%)
FIGURE 83 GLOBAL MARKET SHARES OF ANIMAL THERAPEUTICS AND DIAGNOSTICS BY SELECT COUNTRY, 2016 (%)
COMPETITIVE ANALYSIS
TABLE 139 GLOBAL MARKET SHARES AND REVENUE OF ANIMAL THERAPEUTICS AND DIAGNOSTICS BY MANUFACTURER, 2016 ($ MILLIONS/%)
FIGURE 84 GLOBAL MARKET SHARES OF ANIMAL THERAPEUTICS AND DIAGNOSTICS BY MANUFACTURER REVENUES, 2016 (%)
TABLE 140 MAJOR INDUSTRY PARTICIPATION BY ANIMAL HEALTH
SUPPLIERS
CHAPTER 10 PATENT ANALYSIS
OVERVIEW
INNOVATION IN DRUG DELIVERY
TRANSDERMAL (SPRAY-ON) DRUGS
SUBLINGUAL (UNDER THE TONGUE) DRUGS
EFFERVESCENT TABLET VACCINE DELIVERY
STERILIZATION METHODS
PATENT PRODUCT SEGMENTS
PATENTS FILED BY YEAR
TABLE 141 ANNUAL DISTRIBUTION OF U.S. PATENTS GRANTED ON ANIMAL HEALTH RODUCTS, JAN. 1, 2000-OCT. 1, 2016 (NUMBER)
FIGURE 85 ANNUAL DISTRIBUTION OF U.S. PATENTS GRANTED ON ANIMAL HEALTH RODUCTS, JAN. 1, 2000-OCT. 1, 2016 (NO. OF PATENTS)
INTERNATIONAL PATENTS BY COUNTRY
TABLE 42 HESKA'S ALLERGY AND RESPIRATORY DRUGS BY TARGET
SPECIES
PATENTS ISSUED BY PATENT HOLDER
TABLE 143 DISTRIBUTION OF U.S. PATENTS ON ANIMAL HEALTH PRODUCTS BY PATENT HOLDER, JAN. 1, 1976-OCT. 1, 2016 (NUMBER OF PATENTS)
CHAPTER 11 COMPANY PROFILES
OVERVIEW
TABLE 144 COMPETITOR MARKET POSITION IN ANIMAL THERAPEUTICS AND DIAGNOSTICS BY SEGMENT, 2016 ($ MILLIONS)
PROFILES
ABAXIS INC.
AJINOMOTO CO. INC.
ARATANA THERAPEUTICS INC.
BASF ANIMAL NUTRITION
BAYER ANIMAL HEALTH GMBH
BLUESTAR GROUP-CHINA NATIONAL BLUESTAR CO. LTD.
BOEHRINGER INGELHEIM VETMEDICA INC.
DSM NUTRITIONAL PRODUCTS LTD.
ELANCO ANIMAL HEALTH
EVONIK INDUSTRIES AG
HESKA CORP.
IDEXX LABORATORIES INC.
MERCK ANIMAL HEALTH
MERIAL SAS
MOSAIC CO. (THE)
VIRBAC S.A.
ZOETIS INC.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report